Literature DB >> 2383415

Preventive cardiology education and practice in residency training: residents' attitudes, perceptions, and practices.

C S Scott1, D Leaf, W E Neighbor, D C Schaad, D M Brock, R L Van Citters.   

Abstract

This paper presents results from two studies of primary care residency programs. Study I was a survey of preventive cardiology attitudes and practice-related intentions of internal medicine and family medicine residents from throughout the United States. Study II consisted of an examination of family medicine residents' perceptions regarding preventive practices and a series of 1,528 medical record reviews of their related assessment and counseling practices. The specific aims were to examine residents' perceptions about their residency programs and to determine the percentages of patients who were assessed for and, if necessary, counseled for coronary heart disease prevention. Results indicated that internal and family medicine residents believe that they should be prepared by their residency training to offer these services and that their residencies were preparing most of them to do so. While they report that they intend to assess and counsel patients in these areas, they do not seem to be doing so. The medical record reviews strongly indicated that they are not providing these services at the recommended levels, especially for assessment of and counseling for smoking and blood cholesterol levels.

Entities:  

Mesh:

Year:  1990        PMID: 2383415

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  2 in total

1.  Physicians and nurses can be effective educators in coronary risk reduction.

Authors:  B Peiss; B Kurleto; M Rubenfire
Journal:  J Gen Intern Med       Date:  1995-02       Impact factor: 5.128

2.  A comparison of self-report and chart audit in studying resident physician assessment of cardiac risk factors.

Authors:  D A Leaf; W E Neighbor; D Schaad; C S Scott
Journal:  J Gen Intern Med       Date:  1995-04       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.